Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daito Pharmaceutical Co., Ltd. is a prominent Japanese pharmaceutical company specializing in the development, manufacturing, and distribution of active pharmaceutical ingredients (APIs) and generic finished dosage forms. Founded in 1942 and headquartered in Toyama, the company has established itself as a key player in the global supply chain, offering extensive contract development and manufacturing organization (CDMO) services. Daito's expertise spans a wide range of therapeutic areas, including the central nervous system, cardiovascular, and gastrointestinal disorders. The company maintains a strategic alliance with Eisai Co., Ltd., which enhances its capabilities in producing high-quality medications. With advanced manufacturing facilities that adhere to global GMP standards, Daito focuses on ensuring the stable supply of essential medicines while pursuing innovation in formulation technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daito.